FindTrial
Sign In

The basis and clinical application of free DNA in the culture fluid of blastocyst

The basis and clinical application of free DNA in the culture fluid of blastocyst

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BPD-17014087
Enrollment
Unknown
Registered
2017-12-21
Start date
2018-01-03
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Disease

Interventions

Case series:No

Sponsors

Northwest Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The method of fertilization is ICSI 2. The previous ICSI-ET has been pregnant and delivered healthy offspring 3, signed the informed consent to give up the remaining blastocyst

Exclusion criteria

Exclusion criteria: 1. chromosomal abnormalities in one or both sides of a husband and wife (including a chromosome polymorphism)

Design outcomes

Primary

MeasureTime frame
Aneuploidy detection;—

Countries

China

Contacts

Public ContactShi Wenhao

Northwest Women and Children's Hospital

swihao@126.com+86 15771798519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026